The case was brought by the Outsourcing Facilities Association (OFA), a trade group that represents FDA-sanctioned compounding pharmacies, which said that ending the shortage was a reckless and arbitrary decision. The plaintiff also alleged that the FDA made its move to benefit special interests, raise drug prices, and deprive much of the public access to a needed medicine. Pittman did not buy these arguments, but with his ruling filed under seal, his exact reasoning for denying the injunction is unknown
It might not get an inch of the airtime as some of the skincare mainstays you know and love (looking at you, retinol), but glutathione has an impressive CV when it comes to skin health
If your primary goal is not weight loss: GLP-1 medications show promise beyond weight management
#503b #503a #FDA | Olympia Pharmaceuticals
4356-4373 [7] : Khaniri E, Bagheripoor-Fallah N., Sohrabvandi S
Wegovy HD is delivered through a single-dose prefilled pen